Obesity Market Research Reports & Industry Analysis
Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than 100 million people in the United States are actively involved in a weight loss or weight management plan at any one time throughout the year. This suggests a demand for products and services which will continue for years to come.
The definitions or measurement characteristics for overweight and obesity have varied over time. The varied definitions affect prevalence statistics and make it difficult to compare data from different studies. The prevalence of overweight and obesity is commonly assessed by using body mass index (BMI). A BMI over 25 kg/m2 is defined as overweight, and a BMI of over 30 kg/m2 as obese. These markers provide the common benchmarks for assessment, but the risks of disease in all populations can increase progressively from lower BMI levels.
According to the World Health Organization, adult mean BMI levels of 22-23 kg.m2 are found in Africa and Asia, while levels of 25-27 kg.m2 are prevalent across North America, Europe, and in some Latin American, North African and Pacific Island countries. BMI increases among middle-aged elderly people, who are at the greatest risk of health complications. In countries undergoing nutrition transition, overnutrition often coexists with undernutrition. People with a BMI below 18.5 kg/m2 tend to be underweight.
Obesity Industry Research & Market Reports
-
Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a ... Read More
-
North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The North America clinical trials market is expected to grow from US$ 27,322.28 million in 2022 to US$ 36,818.15 million by 2028. It is estimated to grow ... Read More
-
Asia Pacific Clinical Trials Market Forecast to 2028 – Regional Analysis – by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Asia Pacific clinical trials market is expected to grow from US$ 8,670.68 million in 2022 to US$ 13,114.04 million by 2028. It is estimated to grow ... Read More
-
Enteral Feeding Devices Market, By Product Type ( Feeding Tubes( Nasogastric Tube with ENFit Connector, Orogastric Tube, Nasoenteric Tube, Oroenteric Tube, Gastrostomy Tube (G Tube) with ENFit Connector, Jejunostomy Tubes), By Age Group (ediatric, Adults), By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Enteral Feeding Devices Market, By ... Read More
-
Bariatric Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028. Bariatric surgery devices refer to the clinical equipment used for conducting bariatric procedures. These procedures aid in weight ... Read More
-
Intragastric Balloons Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 111.1 Million by 2028, exhibiting a growth rate (CAGR) of 11.9% during 2023-2028. An intragastric balloon is a saline- or gas-filled inflatable silicone balloon that is temporarily placed inside the stomach for losing ... Read More
-
Obesity Surgery Device Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... to register an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Obesity Surgery Device Market Outlook ... Read More
-
Metabolism Assays Market by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028
... to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 7.8% during the forecast period. The growth of this market is majorly driven by the promotion of metabolic ... Read More
-
Cardiometabolic Diseases Global Market Report 2023 Including: 1) By Type: Chronic/Congestive Heart Failure; Hypertension; Type 2 Diabetes; Obesity 2) By Treatment: ACE inhibitors; Diuretics; Glucophage; Liposuction 3) By Dosage: Tablet; Injection 4) By Route Of Administration: Oral; Intravenous 5) By End-Users: Clinic; Hospital Covering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; AbbVie Inc.
... By End-Users: Clinic; HospitalCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; AbbVie Inc. Cardiometabolic Diseases Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Obesity Intervention Devices Market - Global Obesity Intervention Devices Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product Coverage, By End User Coverage, By Geographic Coverage and Leading Companies)
... Obesity Intervention Devices Market Poised to Reach Nearly $0.5 Billion by 2030 The global obesity intervention devices market is on an upward trajectory, with a forecasted valuation of close to $0.5 billion by the year ... Read More
-
Global Anti-Obesity Drugs Market - 2023-2030
... period 2023-2030. Obesity is a health disorder with surplus body fat gathered to an magnitude that it may generate a harmful consequence on health. It is typically comprehended as owning a body mass index (BMI) ... Read More
-
Digital Therapeutics Market Size, Share, and Analysis, By Type (Devices, Software & Services), By Application (Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases, Others), By End User (Patients, Providers, Payers, Employers, Others) and Regional Forecasts, 2022-2032
... Forecasts, 2022-2032 Digital Therapeutics Market Size, Share, and Analysis, By Type (Devices, Software & Services), By Application (Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases, Others), By End User (Patients, Providers, Payers, Employers, Others) ... Read More
-
Obesity Surgery Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented ... Read More
-
Laparoscopic Devices Market Size, Share & Trends Analysis - Europe - 2023-2029 - MedSuite - Includes: Laparoscopes, Access Devices, Closure Devices, and 9 more
... with strong market shares. This comprehensive market analysis reviewed over 55 companies across Europe, employing in-depth methodologies to assess market size, unit sales, and company shares while also developing reliable forecasts. The European laparoscopic device ... Read More
-
Well-Being Platform Market Forecast to 2030 - Global Analysis by Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Well-Being, and Others), Category (Fitness and Nutrition Consultant, Psychological Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography
... Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography The well-being platform market is expected to grow from US$ 449.21 billion in 2022 ... Read More
-
Endothelial Dysfunction Market Forecast to 2028 - Global Analysis by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The global endothelial dysfunction market size was valued at US$ 1,995.17 million in 2022 and is expected to reach ... Read More
-
North America Bariatric Surgery Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.31 billion by 2028, at a CAGR of 5.45% during the forecast period (2023-2028). Elective surgeries, including bariatric surgery, were restricted during the pandemic, and the willingness to seek medical treatment also changed. The ... Read More
-
Bioimpedance Analyzers Market by Type (Single, Multi & Dual Frequency), Modality (Wired, Wireless), Application (Segmental Body Measurement, Whole Body Measurement), End User (Fitness Clubs, Home Users, Hospitals), & Region- Global Forecast to 2028
... bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. The growth of this market is majorly driven ... Read More
-
Global Obesity Market (2023 Edition) – Analysis By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Others), Age Group, By Gender, By Region, By Country: Drivers, Trends and Forecast to 2029
... has released a research report titled “Global Obesity Market (2023 Edition)” which provides a complete analysis of the Global Obesity Industry By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Other Drugs), Age Group (0-18 ... Read More
-
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032
... Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the dyslipidemia market through 2032. Examples of key findings from this report include the following - 2022 base year sales within the dyslipidemia market ... Read More
-
Global Metabolism Drugs Market Size study & Forecast, by Drug Type (Antidiabetic Drugs, Lipid Lowering Drugs, Anti-Obesity Drugs, Thyroid Hormone Drugs, Others) by Indication (Diabetes, Hyperlipidaemia, Obesity, Hypothyroidism) and Regional Analysis, 2023-2030
... Market is valued approximately at USD 16.10 billion in 2022 and is anticipated to grow with a growth rate of more than 6.50% over the forecast period 2023-2030. A metabolism drug refers to a medication ... Read More
-
Pet Obesity Management Market - By Product (Drugs, Food Supplements), Animal Type (Dogs, Cats), Distribution Channel (Pet Specialty Stores, E-commerce), Global Forecast 2023 - 2032
... 7% CAGR from 2023-2032, driven by the increasing number of veterinary professionals recommending weight management programs, therapeutic diets, and medications. The increasing prevalence of pet obesity, attributed to sedentary lifestyles and poor dietary habits has ... Read More
-
Weight Loss And Obesity Management Market
... Share, Outlook, and Opportunity Analysis, 2023 - 2030 Overweight and obesity are defined as abnormal or excessive amounts of fat that pose a threat to health. Overweight is defined as having a body mass index ... Read More
-
Clinical Trials Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular Disease, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular Disease, and Others) The clinical trials market size is expected to reach US$ 25,476.86 million by 2028 from US$ 17,343.46 million in 2022; it is estimated to record a ... Read More
-
Clinical Trials Market Forecast to 2028 - Global Analysis by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular Disease, and Others)
... Diabetes, Obesity, Cardiovascular Disease, and Others) The clinical trials market size is expected to reach US$ 25,476.86 million by 2028 from US$ 17,343.46 million in 2022; it is estimated to record a CAGR of 6.8% ... Read More
Research Assistance
